In talks with multinational pharma firms for brands acquisition: Bafna Pharma

Published On 2021-11-15 04:30 GMT   |   Update On 2021-11-15 13:02 GMT

New Delhi: Pharmaceuticals formulations major Bafna Pharmaceuticals Ltd was in advanced stage of discussion with some multi-national pharma companies for acquisitions of brands, a company official said.

The city-based company declared its financial results for the quarter ending September 30, 2021 with standalone net at Rs 2.37 crore as against Rs 47 lakh registered during same quarter of previous year.

For the half year period ending September 30, 2021 standalone profit stood at Rs 4.46 crore from Rs 2.29 crore registered during corresponding period of last financial year, a company statement said here on Sunday.
''..with the Covid-19 pandemic nearly behind us, the company is looking at a quantum growth in income as well as (in) profits. We are engaged in advanced-level talks with some multinational pharma companies for acquisition of brands'', company
Advertisement
Head-Business Development Navin Bafna
said in the statement.
The total income on standalone basis during the quarter ending September 30, 2021 grew to Rs 28.61 crore from Rs 15.42 crore registered same period last fiscal. Standalone total income for the six month period ending September 30, 2021 was at Rs 50.04 crore as against Rs 32.30 crore registered during the same period of last fiscal.
The Earnings Before Interest Depreciation and Amortization (EBITDA) for the half year ending September 30, 2021 was at Rs 7.43 crore, as against Rs 4.28 crore registered in the same period of last financial year, the statement added.


Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News